Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GPhA State Affairs Head Bruce Lott Joins From PhRMA

Executive Summary

Generic Pharmaceutical Association Senior Director-State Affairs Bruce Lott will bring experience in media relations on the brand name side of the industry when he joins the trade group the week of Sept. 15

Generic Pharmaceutical Association Senior Director-State Affairs Bruce Lott will bring experience in media relations on the brand name side of the industry when he joins the trade group the week of Sept. 15.

Lott joins GPhA from the Pharmaceutical Research & Manufacturers of America, where he served as senior director-public affairs. Lott announced his resignation from PhRMA Sept. 9.

GPhA wants to work with states on developing programs to maximize generic utilization, including preferred drug lists, step therapy and permissive substitution. The association is also concerned about proposals to require supplemental rebates from generic manufacturers.

State affairs had been handled at GPhA by Suzanne Charleston, who joined the association at the beginning of 2003 from the Pharmaceutical Care Management Association (1 (Also see "GPhA Adds Legislative Staffer For Republican Focus, Creates PAC" - Pink Sheet, 16 Dec, 2002.), p. 21). Charleston, however, left GPhA earlier this year.

Lott's move is a relatively rare example of a staff level switch from the brand name trade association to the generic side.

Following the 2000 creation of GPhA, Generic Pharmaceutical Industry Association President Alice Till, PhD, joined PhRMA as VP-science policy & technical affairs (2 (Also see "PhRMA Technical Affairs VP Till Joins From GPhA" - Pink Sheet, 30 Oct, 2000.), p. 17).

Till's predecessor at GPIA, Lewis Engman, had previously been president of the Pharmaceutical Manufacturers Association, although he spent a decade in other pursuits before joining GPIA.

PhRMA is in the process of rebuilding its communication staff under VP-Communications Ed Belkin, who joined the association in August (3 (Also see "PhRMA VP-Communications Belkin Is Veteran Of Clinton Health Care Debate" - Pink Sheet, 21 Jul, 2003.), p. 11).

Lott is one of five members of the PhRMA communications team who have left the association in the past two months (see 4 (Also see "PhRMA Communications Staff Adds State Affairs, Editorial Services Directors" - Pink Sheet, 15 Sep, 2003.)).

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS042462

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel